REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Amgen Biotechnologia Sp. z o.o. (Poland)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Amgen Biotechnologia Sp. z o.o. Profile Updated: September 28, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Amgen Biotechnologia Sp. z o.o is a biotech company. The company focuses on developing therapies for severe diseases such as cancer, kidney failure, osteoporosis, and rheumatoid arthritis. Amgen uses genetic engineering to discover and deliver drugs based on molecular biology and DNA recombination. The company is dedicated to providing therapeutic solutions to patients worldwide.

Headquarters
Ul. Pulawska 145
Warsaw; Mazowieckie; Postal Code: 02-715

Contact Details: Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.

Website: http://www.amgen.pl

Basic Information
Total Employees:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Incorporation Date:
September 26, 2011
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Amgen Biotechnologia Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-1.14%▼
Total operating revenue
-1.14%▼
Operating profit (EBIT)
1.5%▲
EBITDA
0.49%▲
Net Profit (Loss) for the Period
9.67%▲
Total assets
10.61%▲
Total equity
29.54%▲
Operating Profit Margin (ROS)
0.18%▲
Net Profit Margin
0.56%▲
Return on Equity (ROE)
-4.13%▼
Debt to Equity Ratio
0.69%▲
Quick Ratio
0.48%▲
Cash Ratio
-1.58%▼

Similar companies

Walutaexpress Sp. z o.o.
 
Metinvest Polska Sp. z o.o.
Verbio Polska Sp. z o.o.
 
Trans Selekt Sp. z o.o.
Venor Polska Sp. z o.o.
 
New Balance Poland Sp. z o.o.
"Mc Diam" Sp. z o.o.
 
Krismar K. Duda, M. Lawicki sp. j.
Nho Nhan Sp. z o.o.
 
Asp Group Pl Sp. z o.o.
Kemppi Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo